Genome-Wide Association Analysis in Primary Sclerosing Cholangitis And Ulcerative Colitis Identifies Risk Loci at Gpr35 And Tcf4
Hepatology2012Vol. 58(3), pp. 1074–1083
Citations Over TimeTop 10% of 2012 papers
David Ellinghaus, Trine Folseraas, Kristian Holm, Eva Ellinghaus, Espen Melum, Tobias Balschun, Jon K. Laerdahl, Alexey Shiryaev, Daniel Gotthardt, Tobias J. Weismüller, Christoph Schramm, Michael Wittig, Annika Bergquist, Einar S. Björnsson, Hanns–Ulrich Marschall, Morten Vatn, Andreas Teufel, Christian Rust, Christian Gieger, H‐Erich Wichmann, Heiko Runz, Martina Sterneck, Christian Rupp, Felix Braun, Rinse K. Weersma, Cisca Wijmenga, Cyriel Y. Ponsioen, Christopher G. Mathew, Paul Rutgeerts, Séverine Vermeire, Erik Schrumpf, Johannes R. Hov, Michael P. Manns, Kirsten Muri Boberg, Stefan Schreiber, André Franke, Tom H. Karlsen
Abstract
By refining the analysis of a PSC GWAS by parallel assessments in a UC GWAS, we were able to detect two novel risk loci at genome-wide significance levels. GPR35 shows associations in both UC and PSC, whereas TCF4 represents a PSC risk locus not associated with UC. Both loci may represent previously unexplored aspects of PSC pathogenesis.
Related Papers
- → Gene and pathway-based second-wave analysis of genome-wide association studies(2009)240 cited
- → Lessons and implications from association studies and post-GWAS analyses of cervical cancer(2014)59 cited
- → Neutrophil autoantibodies: A genetic marker in primary sclerosing cholangitis and ulcerative colitis(1994)171 cited
- → HLA antigens in ulcerative colitis and primary sclerosing cholangitis(1995)38 cited
- → A Comparison of Primary Sclerosing Cholangitis with and Without Associated Inflammatory Bowel Disease: Data from the Pediatric PSC Consortium(2017)2 cited